OTC Healthcare in Austria
Euromonitor International's OTC Healthcare in Austria market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 93 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Cough, cold and allergy (hay fever) remedies has strongest influence on sales
Sales of OTC Healthcare grew to EUR429 million in 2005: a healthy 4% current value increase in 2005 compared to a weaker growth in 2004. This was mainly due to the strong development of cough, cold and allergy (hay fever) remedies and some additional sales of vitamins and dietary supplements. These were the two largest sectors in OTC Healthcare in Austria in 2005.
Main driver of OTC Healthcare 2005 is longer, stronger flu season
The main reason for this development was a stronger and longer cold and flu season at the beginning, as well as at the end of 2005. This resulted in 5% additional sales of cough, cold and allergy (hay fever) remedies.
The winter was not a big exception but still generated an additional demand for OTC Healthcare products. This also shows that OTC Healthcare sales are quite seasonal as well as more difficult to predict as, mainly, sales are demand driven and only a few Austrians can be convinced to take a pill unnecessarily.
Bayer boosts its overall shares with the acquisition of Roche’s OTC brands
With the takeover of all OTC brands from Roche Austria GmbH, effective from 1 January 2005, Bayer Austria GmbH acquired the leadership of OTC Healthcare sales in Austria with 11% value sales. This enabled Bayer to position itself in sectors and subsectors where it did not previously have any brands.
Low level of product development in 2005
2005 saw a small number of new product developments. The forced-switching regulation (introduced in 2002) continued to make no practical impact, despite the existence of a large number of switched substances. This was mainly due to the smallness of the sectors and, therefore, the unwillingness of manufacturers to invest in research and development as well as in marketing in order to raise general acceptance of OTC Healthcare products.
Some sectors, for example, calming and sleeping products, saw a trend toward more herbal products. This was not true for overall OTC Healthcare as, for instance, analgesics experienced a slight shift toward standard products.
Chemists/pharmacies dominates retail
The regulation of OTC Healthcare products’ distribution was relaxed by Austrian health authorities in order to lessen the strain on the healthcare system. The laws concerning chemists/pharmacies in Austria are particularly rigorous. For instance, chemists/pharmacies is not allowed to form a chain, and has very restrictive shop layouts. Also, it is very difficult to open chemists/pharmacies.
Established chemists/pharmacies embraces these regulations as it protects it from direct competitors. Drugstores/parapharmacies chains, especially DM-Drogeriemarkt, is trying to lobby for more products being allowed through additional outlets – with some success. The regulatory bodies approved some switches and new registrations for OTC Healthcare products to be sold in drugstores/parapharmacies. However, manufacturers are afraid of losing their good partnership with chemists/pharmacies. Normally, OTC Healthcare is a smaller division compared to manufacturers’ Rx products, so they limit their products to being marketed through chemists/pharmacies.
Table of contents
OTC HEALTHCARE IN AUSTRIA : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Medicine Consumption in Austria
Table 2 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 3 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 6 OTC Healthcare Switches 2004-2005
Competitive Environment
Table 7 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 8 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Table 11 Penetration of Private Label by Sector 2001-2005
Forecast Market Performance
Table 12 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 13 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - AUSTRIA
APOMEDICA GMBH & CO KG - OTC HEALTHCARE - AUSTRIA
COMPANY BACKGROUND
RECENT NEWS
PRODUCTION CAPACITY
BOEHRINGER INGELHEIM AUSTRIA GMBH - OTC HEALTHCARE - AUSTRIA
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Boehringer Ingelheim Austria GmbH Operational Indicators 2004
PRODUCTION CAPACITY
KWIZDA F JOH GMBH - OTC HEALTHCARE - AUSTRIA
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Kwizda F Joh GmbH: Operational Indicators 2003
PRODUCTION CAPACITY
SANOVA PHARMA GESMBH - OTC HEALTHCARE - AUSTRIA
COMPANY BACKGROUND
RECENT NEWS
PRODUCTION CAPACITY
ANALGESICS IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
Analgesics sales growth recovers in 2005 from a slowdown in 2004
Adult analgesics drives sales due to severe flu season
Naproxen and ibuprofen are most dynamic subsectors
Bayer Austria takes lead position from Boehringer Ingelheim Austria
Child-specific analgesics
Topical analgesics/anaesthetic
Forecast performance
Table 14 Sales of Analgesics by Subsector: Value 2000-2005
Table 15 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 16 Analgesics Company Shares by Retail Value 2001-2005
Table 17 Analgesics Brand Shares by Retail Value 2002-2005
Summary 3 Summary - Analgesics: New Product Launches 2004-2005
Table 18 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS/ANAESTHETIC BY HERBAL/STANDARD SPLIT
Table 20 Herbal vs Standard Topical Analgesics/anaesthetic 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
Growth back to 5% in 2005 after a slump in 2004, due to a 'good' cold season
Strong growth rate for antihistamines/allergy remedies (systemic) from low level
Cough remedies drives growth
Combination products grows again in 2005
Procter & Gamble leads and Bayer gains share
Forecast performance
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 4 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Table 27 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Decongestants growth goes hand in hand with demand for cough and cold products
Ocean water nasal sprays splash up
Table 28 Sales of Decongestants by Type: Value 2000-2005
Table 29 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Table 30 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 31 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
Additional sales generated mainly by indigestion and heartburn remedies and diarrhoeal remedies
Forecast performance
Table 32 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 33 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 34 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 35 Digestive Remedies Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Digestive Remedies: New Product Launches 2004-2005
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Table 38 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
Table 39 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 40 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
Sales of medicated skin care back on track from weak growth in 2004
Clearasil drives acne treatments and, with it, overall sales
Product innovation in nappies and diapers reduces demand for children’s products
Bayer now second strongest player in medicated skin care in 2005
Forecast performance
Table 41 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 42 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 43 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 44 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 6 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Table 47 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Table 48 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Table 49 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
Slight improvment in vitamins and dietary supplements sales in 2005
Tonics and bottled nutritive drinks suffers from inconvenience and old image
Sectoral growth in Austria driven especially by mineral supplements, other dietary combination formulas and fish oils
Mass-market and chemists/pharmacies from two distinct distribution paths
New leader with Bayer, due to former Roche brands
Forecast performance
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 51 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Summary 7 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
Table 54 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
Table 56 Sales of Vitamins by Type: Value 2000-2005
Table 57 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 58 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Table 59 Sales of Dietary Supplements by Type: Value 2000-2005
Table 60 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 61 Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 62 Dietary Supplements by Positioning: % Retail Value Analysis 2005
NRT SMOKING CESSATION AIDS IN AUSTRIA
NUMBER OF SMOKERS
Table 63
SECTOR PERFORMANCE
2005 headlines
Sales of NRT smoking cessation aids in 2005 at an all-time high
NRT inhalators shows strongest percentage growth
Gum, oldest and largest subsector, drives sales
Nicorette, then Nicotinell follows
Forecast performance
Table 64 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 65 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 66 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 67 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Summary 8 Summary - NRT Smoking Cessation Aids: New Product Launches 2004-2005
Table 68 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 69 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
EYE CARE IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
2005 sees healthy growth but slightly lower than in 2004
Standard eye care outperforming allergy eye care for yet another year
Prescription-generated sales keep OTC allergy ear care sales low
Forecast performance
Table 70 Sales of Eye Care by Subsector: Value 2000-2005
Table 71 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 72 Eye Care Company Shares by Retail Value 2001-2005
Table 73 Eye Care Brand Shares by Retail Value 2002-2005
Summary 9 Summary - Eye Care: New Product Launches 2004-2005
Table 74 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 75 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN AUSTRIA
SECTOR PERFORMANCE
ADULT MOUTHCARE IN AUSTRIA
SECTOR PERFORMANCE
Summary 10 Summary - Adult Mouthcare: New Product Launches 2004-2005
CALMING AND SLEEPING PRODUCTS IN AUSTRIA
SECTOR PERFORMANCE
Summary 11 Summary - Calming and Sleeping Products: New Product Launches 2004-2005
WOUND TREATMENTS IN AUSTRIA
SECTOR PERFORMANCE
2005 headlines
2005 sales up by 5% in current value terms after stagnating 2004 sales, driven by product innovations
Other wound treatments sees strongest growth rate but sticking plasters drives sales
Forecast performance
Table 76 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 77 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 78 Wound Treatments Company Shares by Retail Value 2001-2005
Table 79 Wound Treatments Brand Shares by Retail Value 2002-2005
Summary 12 Summary - Wound Treatments: New Product Launches 2004-2005
Table 80 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 81 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN AUSTRIA
SECTOR PERFORMANCE